Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04246996 · ClinicalTrials.gov registry record · Phase 2
Gentamicin Intravesical Efficacy for Infection of Urinary Tract
A Phase 2 study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 2
- Development phase
- 370
- Enrollment target
NCT04246996 is a Phase 2 study that has completed, run by Kaiser Permanente. The registered enrollment target is 370 participants.
The verdict
NCT04246996, a Phase 2 study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 370 participants
- Enrollment target
Study Summary
Urinary tract infection (UTI) is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence. This prospective, randomized, single-masked (subject), two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gentamicin sulfate in 50 mL of saline versus usual care on the proportion of women treated for UTI within 6 weeks following surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI).
Interventions
- DRUG gentamicin sulfate
- OTHER Catheter clamping only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 370 participants |
| Start Date | 2020-01-29 |
| Est. Completion | 2021-12-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04246996
The ClinicalTrials.gov registry entry for NCT04246996 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 370 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which gentamicin sulfate is the first listed.
NCT04246996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04246996 about?
NCT04246996 is a clinical study titled "Gentamicin Intravesical Efficacy for Infection of Urinary Tract". Urinary tract infection (UTI) is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence. This prospective, randomized, single-masked (subject), two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gent...
What is the current status of trial NCT04246996?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 370 participants. The study started on 2020-01-29. Estimated completion is 2021-12-05.
What interventions are being tested in trial NCT04246996?
The interventions under investigation include: gentamicin sulfate (DRUG), Catheter clamping only (OTHER).
Who is sponsoring clinical trial NCT04246996?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.